Medsender secured a $5 million Series A investment from Ballast Point Ventures to enhance its AI-driven workflow automation platform for healthcare providers.

Information on the Target

Medsender is an innovative AI-powered workflow automation platform designed specifically for healthcare providers. With its robust capabilities, Medsender is trusted by thousands of healthcare organizations across all fifty states to alleviate administrative burdens significantly. The platform harnesses artificial intelligence to process and synchronize data from unstructured sources such as faxes, emails, and phone calls, effectively automating various administrative workflows and enhancing patient communications.

Notably, Medsender allows healthcare providers to streamline operations by automating complex processes such as referral processing, patient scheduling, and request management. This technology enables providers to concentrate on delivering high-quality care, rather than getting bogged down by administrative tasks. Medsender's integration with MAIRA™, a human-like AI phone agent, can reduce call-handling times by as much as 80%, contributing to an overall enhanced operational efficiency.

Industry Overview in the United States

The healthcare industry in the United States is currently undergoing a significant transformation driven by technological advancements and an increased demand for operational efficiency. As healthcare providers look for ways to improve patient care while man

View Source

Similar Deals

Broadview Ventures and Advent Life Sciences Relief Cardiovascular

2025

Series A Medical Devices & Implants United States of America
SPRIM Global Investments and William Taylor Nominees RheumaGen, Inc.

2025

Series A Bio Therapeutic Drugs United States of America
Plural Teton.ai

2025

Series A Residential & Long-Term Care United States of America
New Markets Venture Partners FamilyWell Health

2025

Series A Hospitals, Clinics & Primary Care Services United States of America
Treo Ventures SecondWave Systems, Inc.

2025

Series A Proprietary & Advanced Pharmaceuticals United States of America
Five Elms Capital Motivity

2025

Series A Healthcare Facilities & Services (NEC) United States of America

Ballast Point Ventures

invested in

Medsender

in 2025

in a Series A deal

Disclosed details

Transaction Size: $5M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert